Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients

Epilepsia

Volumn 54, Issue 9, 2013, Pages

  Mao, Ling Yan ^a   Ding, Jing ^a   Peng, Wei Feng ^a   Ma, Yu ^a   Zhang, Yu Hao ^a   Fan, Wei ^a   Wang, Xin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Cytokines; Epilepsy; Interleukin 17; Seizure severity

Indexed keywords

ANTICONVULSIVE AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE DURATION; DISEASE SEVERITY; EPILEPSY; HUMAN; IDIOPATHIC INFLAMMATORY DEMYELINATING DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SEIZURE;

CYTOKINES; EPILEPSY; INTERLEUKIN-17; SEIZURE SEVERITY;

ADULT; EPILEPSY; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; UP-REGULATION;

EID: 84883740752     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12337     Document Type: Article

References (12)

1. Cramer JA, French J,. (2001) Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components. Epilepsia 42: 119-129.
2. Engel JJ,. (2006) ILAE classification of epilepsy syndromes. Epilepsy Res 70 (Suppl. 1): S5-S10.
3. He JJ, Li S, Shu HF, Yu SX, Liu SY, Yin Q, Yang H,. (2013) The interleukin 17 system in cortical lesions in focal cortical dysplasias. J Neuropathol Exp Neurol 72: 152-163.
4. Jadidi-Niaragh F, Mirshafiey A,. (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74: 1-13.
5. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A,. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13: 1173-1175.
6. Lehtimaki KA, Keranen T, Huhtala H, Hurme M, Ollikainen J, Honkaniemi J, Palmio J, Peltola J,. (2004) Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol 152: 121-125.
7. Li S, Yu M, Li H, Zhang H, Jiang Y,. (2012) IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barre syndrome. Mediators Inflamm 2012: 260473.
8. Miossec P, Korn T, Kuchroo VK,. (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
9. Montes M, Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S,. (2009) Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 130: 133-144.
10. Muller M, Fontana A, Zbinden G, Gahwiler BH,. (1993) Effects of interferons and hydrogen peroxide on CA3 pyramidal cells in rat hippocampal slice cultures. Brain Res 619: 157-162.
11. Samland H, Huitron-Resendiz S, Masliah E, Criado J, Henriksen SJ, Campbell IL,. (2003) Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 73: 176-187.
12. Vezzani A, French J, Bartfai T, Baram TZ,. (2011) The role of inflammation in epilepsy. Nat Rev Neurol 7: 31-40.